对《miR-182-5p通过抑制FOXO3a促进肝细胞癌进展》的更正
Correction to: miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a.
作者信息
Cao Man-Qing, You A-Bin, Zhu Xiao-Dong, Zhang Wei, Zhang Yuan-Yuan, Zhang Shi-Zhe, Zhang Kei-Wei, Cai Hao, Shi Wen-Kai, Li Xiao-Long, Li Kang-Shuai, Gao Dong-Mei, Ma De-Ning, Ye Bo-Gen, Wang Cheng-Hao, Qin Cheng-Dong, Sun Hui-Chan, Zhang Ti, Tang Zhao-You
机构信息
Department of Hepatobiliary Surgery, Liver Cancer Institute and Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, China.
Department of Hepatobiliary Surgery, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, 300060, China.
出版信息
J Hematol Oncol. 2018 Apr 18;11(1):56. doi: 10.1186/s13045-018-0599-z.
The original article [1] contains an error in Fig. 5a whereby the Western blot bands representing CyclinD1 have mistakenly been duplicated over the Western blot bands intended to represent SGK.
原文章[1]中图5a存在一处错误，即代表细胞周期蛋白D1的蛋白质印迹条带被错误地复制到了原本打算代表血清和糖皮质激素诱导激酶的蛋白质印迹条带上。
Zotero 插件